Trials / Completed
CompletedNCT00035568
A Research Study to Assess the Mechanism By Which Glucovance, Metformin, and Glyburide Work To Control Glucose Levels In Patients With Type 2 Diabetes
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical research study is to support earlier observations that Glucovance controls glucose levels after a mean, and improves overall glucose control better than metformin or glyburide therapy alone in adults with type 2 diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Glucovance (metformin HCl/glyburide) | |
| DRUG | or Metformin HCl alone | |
| DRUG | or Glyburide alone. |
Timeline
- Start date
- 2002-02-01
- Primary completion
- 2003-06-01
- Completion
- 2003-06-01
- First posted
- 2002-05-06
- Last updated
- 2011-04-15
Locations
9 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00035568. Inclusion in this directory is not an endorsement.